Agilent Technologies, Inc. (NYSE:A) Shares Sold by Swiss National Bank

Swiss National Bank trimmed its position in Agilent Technologies, Inc. (NYSE:A) by 3.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 914,900 shares of the medical research company’s stock after selling 35,200 shares during the period. Swiss National Bank owned 0.31% of Agilent Technologies worth $127,199,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. MV Capital Management Inc. increased its position in shares of Agilent Technologies by 120.7% in the 4th quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock valued at $27,000 after acquiring an additional 105 shares during the period. OFI Invest Asset Management acquired a new position in shares of Agilent Technologies in the 3rd quarter valued at $25,000. Baystate Wealth Management LLC increased its position in shares of Agilent Technologies by 107.3% in the 4th quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock valued at $36,000 after acquiring an additional 133 shares during the period. Turtle Creek Wealth Advisors LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $39,000. Finally, Rosenberg Matthew Hamilton increased its position in shares of Agilent Technologies by 51.1% in the 4th quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock valued at $39,000 after acquiring an additional 96 shares during the period.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Oppenheimer upped their price target on shares of Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a report on Tuesday, March 26th. Evercore ISI upped their price target on shares of Agilent Technologies from $132.00 to $145.00 and gave the company an “in-line” rating in a report on Thursday, April 4th. Stifel Nicolaus raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and upped their price target for the company from $145.00 to $163.00 in a report on Friday, April 5th. Citigroup upped their price target on shares of Agilent Technologies from $130.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, February 28th. Finally, UBS Group upped their price target on shares of Agilent Technologies from $130.00 to $155.00 and gave the company a “neutral” rating in a report on Wednesday, February 28th. One analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $141.29.

Agilent Technologies Trading Up 1.4 %

A opened at $139.47 on Friday. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $151.58. The company has a market cap of $40.87 billion, a P/E ratio of 33.21, a PEG ratio of 4.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.04 and a current ratio of 2.68. The business’s 50-day simple moving average is $141.92 and its 200-day simple moving average is $131.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.07. Agilent Technologies had a return on equity of 27.09% and a net margin of 18.35%. The firm had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the business earned $1.37 earnings per share. The company’s revenue for the quarter was down 5.5% compared to the same quarter last year. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.5 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 24th. Shareholders of record on Tuesday, April 2nd were issued a $0.236 dividend. The ex-dividend date was Monday, April 1st. This represents a $0.94 annualized dividend and a yield of 0.68%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.38%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 52,297 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $150.00, for a total transaction of $7,844,550.00. Following the transaction, the chief executive officer now owns 253,909 shares of the company’s stock, valued at $38,086,350. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, CEO Michael R. Mcmullen sold 52,297 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $150.00, for a total value of $7,844,550.00. Following the completion of the sale, the chief executive officer now directly owns 253,909 shares in the company, valued at approximately $38,086,350. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Heidi Fields sold 1,658 shares of the business’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $144.34, for a total transaction of $239,315.72. Following the completion of the transaction, the director now owns 54,976 shares in the company, valued at approximately $7,935,235.84. The disclosure for this sale can be found here. Insiders have sold 61,610 shares of company stock worth $9,220,333 over the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.